SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial ResultsGlobeNewsWire • 10/27/22
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of MonkeypoxGlobeNewsWire • 10/12/22
SIGA Stock Alert: Siga Technologies Receives $11 Million Order for Monkeypox DrugInvestorPlace • 09/29/22
SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®GlobeNewsWire • 09/29/22
SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)GlobeNewsWire • 09/26/22
SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®GlobeNewsWire • 08/09/22
SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/07/22